BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.
To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.
To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.
The prevalence of opioids in California workers compensation lost-time claims has dropped 51% over the past decade, reducing both average benefit payments and average days away from work on those claims, according to a study released Wednesday by the California Workers’ Compensation Institute.
The Oakland, California-based institute also found that 10-year costs on 2010 through 2017 claims systemwide are projected to decline by an estimated $6.5 billion, according to the report.
The study’s authors analyzed 273,106 lost-time claims in which treatment was initiated within a 10-year period between 2008 and 2017, with payment and prescription data on the claims valued through 2018.
The authors found that over the 10-year span of the study, chronic opioid use — defined as three or more opioid prescriptions, each filled at least three weeks apart, and all filled within four consecutive months — declined from 13% to 3% of all lost-time claims. This represents a relative decline of 77%, according to the study, which also found opioid claims that fell outside of the chronic classification and were labeled as “acute” declined from about 36% to just over 21% of the claims — a relative decline of 40%.
The study also showed that the strength of the opioids dispensed within the first 12 months of treatment, measured in cumulative morphine milligram equivalents as a common yardstick for medication strength, declined 59% for chronic opioid use claims, and 36% for acute opioid use claims.
(Reuters) — Several U.S. states that have been ravaged by the opioid epidemic are pushing back on a proposed $48 billion settlement framework that would resolve thousands of lawsuits against five drug companies accused of fueling the addiction crisis.